was read the article
array:23 [ "pii" => "S2173509314001226" "issn" => "21735093" "doi" => "10.1016/j.endoen.2014.06.013" "estado" => "S300" "fechaPublicacion" => "2014-08-01" "aid" => "578" "copyright" => "SEEN" "copyrightAnyo" => "2013" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Endocrinol Nutr. 2014;61:347-50" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1475 "formatos" => array:3 [ "EPUB" => 15 "HTML" => 1194 "PDF" => 266 ] ] "itemSiguiente" => array:18 [ "pii" => "S2173509314001214" "issn" => "21735093" "doi" => "10.1016/j.endoen.2014.06.012" "estado" => "S300" "fechaPublicacion" => "2014-08-01" "aid" => "577" "copyright" => "SEEN" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Endocrinol Nutr. 2014;61:351-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1186 "formatos" => array:3 [ "EPUB" => 12 "HTML" => 803 "PDF" => 371 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "351" "paginaFinal" => "358" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Prevalencia de hiperandrogenismo y síndrome de ovario poliquístico en transexuales de mujer a hombre" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Antonio Becerra-Fernández, Gilberto Pérez-López, Miriam Menacho Román, Juan F. Martín-Lazaro, María Jesús Lucio Pérez, Nuria Asenjo Araque, José Miguel Rodríguez-Molina, María Carmen Berrocal Sertucha, María Victorina Aguilar Vilas" "autores" => array:9 [ 0 => array:2 [ "nombre" => "Antonio" "apellidos" => "Becerra-Fernández" ] 1 => array:2 [ "nombre" => "Gilberto" "apellidos" => "Pérez-López" ] 2 => array:2 [ "nombre" => "Miriam" "apellidos" => "Menacho Román" ] 3 => array:2 [ "nombre" => "Juan F." "apellidos" => "Martín-Lazaro" ] 4 => array:2 [ "nombre" => "María Jesús" "apellidos" => "Lucio Pérez" ] 5 => array:2 [ "nombre" => "Nuria" "apellidos" => "Asenjo Araque" ] 6 => array:2 [ "nombre" => "José Miguel" "apellidos" => "Rodríguez-Molina" ] 7 => array:2 [ "nombre" => "María Carmen" "apellidos" => "Berrocal Sertucha" ] 8 => array:2 [ "nombre" => "María Victorina" "apellidos" => "Aguilar Vilas" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173509314001214?idApp=UINPBA00004N" "url" => "/21735093/0000006100000007/v1_201407280036/S2173509314001214/v1_201407280036/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S217350931400124X" "issn" => "21735093" "doi" => "10.1016/j.endoen.2014.06.015" "estado" => "S300" "fechaPublicacion" => "2014-08-01" "aid" => "590" "copyright" => "SEEN" "documento" => "article" "crossmark" => 0 "subdocumento" => "sco" "cita" => "Endocrinol Nutr. 2014;61:345-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1210 "formatos" => array:3 [ "EPUB" => 13 "HTML" => 832 "PDF" => 365 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Bariatric surgery and bone mineral metabolism" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "345" "paginaFinal" => "346" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Cirugía bariátrica y metabolismo mineral óseo" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Nuria Vilarrasa, Carmen Gómez-Vaquero" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Nuria" "apellidos" => "Vilarrasa" ] 1 => array:2 [ "nombre" => "Carmen" "apellidos" => "Gómez-Vaquero" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217350931400124X?idApp=UINPBA00004N" "url" => "/21735093/0000006100000007/v1_201407280036/S217350931400124X/v1_201407280036/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Treatment of subclinical hypothyroidism in pregnancy using fixed thyroxine daily doses of 75<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleBold">μ</span>g" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "347" "paginaFinal" => "350" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Manuel Penin, Cristina Trigo, Yolanda López, María Barragáns" "autores" => array:4 [ 0 => array:4 [ "nombre" => "Manuel" "apellidos" => "Penin" "email" => array:1 [ 0 => "manuelpenin@wanadoo.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Cristina" "apellidos" => "Trigo" ] 2 => array:2 [ "nombre" => "Yolanda" "apellidos" => "López" ] 3 => array:2 [ "nombre" => "María" "apellidos" => "Barragáns" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Endocrinología y Nutrición, Complexo Hospitalario Universitario de Vigo, Vigo, Pontevedra, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Tratamiento del hipotiroidismo subclínico en gestantes con una dosis fija diaria de 75<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleBold">μ</span>g de tiroxina" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Diagnosis and treatment of hypothyroidism in pregnant women are frequently controversial.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Most, but not all,<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> studies show decreased plasma levels of thyroid-stimulating hormone (TSH) during pregnancy,<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3–7</span></a> and both the American thyroid Association (ATA) and the American Association of Clinical Endocrinologists (AACE) recommend use of the following specific normal ranges for pregnant women: first trimester, 0.1–2.5<span class="elsevierStyleHsp" style=""></span>mIU/mL; second trimester, 0.2–3.0<span class="elsevierStyleHsp" style=""></span>mIU/mL; and third trimester, 0.3–3<span class="elsevierStyleHsp" style=""></span>mIU/mL, instead of the standard range used in non-pregnant women (0.3–4.5<span class="elsevierStyleHsp" style=""></span>mIU/mL).</p><p id="par0010" class="elsevierStylePara elsevierViewall">Unlike in frank hypothyroidism, there is no agreement on the indications for treatment in pregnant women with subclinical hypothyroidism (increased TSH levels with normal FT4). The ATA and AACE recommend that only patients with peroxidase antibodies (anti-TPO) or thyroglobulin antibodies (anti-TG) are treated, based on a study which showed increased complications of pregnancy in these patients.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> By contrast, other guidelines advocate treatment of all pregnant women with subclinical hypothyroidism, regardless of plasma levels of thyroid antibodies.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> The goal of treatment, if administered, is to achieve normal TSH levels for each trimester of pregnancy.</p><p id="par0015" class="elsevierStylePara elsevierViewall">There is no agreement either on how to calculate the starting thyroxine dose. Some authors suggest that dose is calculated based on patient weight (1<span class="elsevierStyleHsp" style=""></span>μg/day),<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> while others recommend that dosage is based on TSH levels at diagnosis: 25<span class="elsevierStyleHsp" style=""></span>μg/day if TSH level is 4–8<span class="elsevierStyleHsp" style=""></span>mIU/mL; 50<span class="elsevierStyleHsp" style=""></span>μg/day if TSH level is 8–12<span class="elsevierStyleHsp" style=""></span>mIU/mL; 75<span class="elsevierStyleHsp" style=""></span>μg/day if TSH level is greater than 12<span class="elsevierStyleHsp" style=""></span>mIU/mL.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> A recent report by our group showed that a fixed dose of 50<span class="elsevierStyleHsp" style=""></span>μg thyroxine in pregnant women with subclinical hypothyroidism allowed for maintaining TSH levels ranging from 3.0 to 4.5<span class="elsevierStyleHsp" style=""></span>mIU/mL in approximately 80% of women, regardless of weight and baseline TSH level.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> This study subsequently analyzed the convenience of treating subclinical hypothyroidism in pregnant women with a daily dose of 75<span class="elsevierStyleHsp" style=""></span>μg of thyroxine.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Subjects and methods</span><p id="par0020" class="elsevierStylePara elsevierViewall">A consecutive sample of women with plasma TSH levels higher than 4.5<span class="elsevierStyleHsp" style=""></span>mIU/L was obtained from all women diagnosed with pregnancy in the Vigo health area between January and August 2012. Women with plasma FT4 levels less than 0.93<span class="elsevierStyleHsp" style=""></span>ng/100<span class="elsevierStyleHsp" style=""></span>mL (frank hypothyroidism), those who had ever been treated with thyroxine, and those previously diagnosed with any thyroid disease (including hypothyroidism, hyperthyroidism, goiter, and thyroid nodule) were excluded.</p><p id="par0025" class="elsevierStylePara elsevierViewall">The resulting cohort consisted of 116 pregnant women, all of whom received (as usual in our health area) 200<span class="elsevierStyleHsp" style=""></span>μg/day of potassium iodide at least from the time pregnancy was diagnosed. One of the patients moved to another town in the second trimester of pregnancy, and pregnancy did not reach its term in another four patients.</p><p id="par0030" class="elsevierStylePara elsevierViewall">All pregnant women were informed of diagnosis of subclinical hypothyroidism and the need for treatment with thyroxine. The thyroxine dose of 75<span class="elsevierStyleHsp" style=""></span>μg/day has become our standard since we found in a pregnant cohort that doses of 50<span class="elsevierStyleHsp" style=""></span>μg/day is often inadequate and never excessive in this population.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> All pregnant women signed an informed consent.</p><p id="par0035" class="elsevierStylePara elsevierViewall">All women were prescribed since diagnosis of hypothyroidism a daily dose of 75<span class="elsevierStyleHsp" style=""></span>μg of thyroxine (Eutirox<span class="elsevierStyleSup">®</span> 75) administered 30<span class="elsevierStyleHsp" style=""></span>min before breakfast, regardless of weight, height, presence of thyroid antibodies, or plasma TSH levels. TSH and FT4 levels were tested in all pregnant women 2, 4, and 6 months after diagnosis. When TSH levels in any test were higher than 4.5<span class="elsevierStyleHsp" style=""></span>mIU/mL, thyroxine dose was increased by 25<span class="elsevierStyleHsp" style=""></span>μg/day, and when levels were less than 0.3<span class="elsevierStyleHsp" style=""></span>mIU/mL, thyroxine dose was reduced in the same amount.</p><p id="par0040" class="elsevierStylePara elsevierViewall">Plasma levels of thyroid peroxidase and thyroglobulin antibodies were tested in all pregnant women in the first trimester.</p><p id="par0045" class="elsevierStylePara elsevierViewall">Plasma TSH levels (normal range in our laboratory: 0.3–4.5<span class="elsevierStyleHsp" style=""></span>mcU/mL) were tested using a chemiluminescent immunometric assay (Cobas 6000<span class="elsevierStyleSup">®</span>, Roche, Mannheim, Germany), FT4 levels (0.9–2<span class="elsevierStyleHsp" style=""></span>ng/100<span class="elsevierStyleHsp" style=""></span>mL) and TPO antibodies (0–34<span class="elsevierStyleHsp" style=""></span>IU/mL) using a competitive electrochemiluminescence immunoassay (Cobas 6000<span class="elsevierStyleSup">®</span>, Roche, Mannheim, Germany), and TG antibodies (0–115<span class="elsevierStyleHsp" style=""></span>IU/mL) with a chemiluminescent immunometric assay (Immulite 2000<span class="elsevierStyleSup">®</span>, Siemens, Germany).</p><p id="par0050" class="elsevierStylePara elsevierViewall">Quantitative variables are given as mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>standard deviation. Differences between independent measurements of quantitative variables were analyzed using a Student's test for independent variables. Differences between repeated measurements of quantitative variables were analyzed using a Student's <span class="elsevierStyleItalic">t</span> test for related measurements. Differences with values of <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.05 were considered significant.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Results</span><p id="par0055" class="elsevierStylePara elsevierViewall"><a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a> shows the age, gestational age, and changes over time in weight and TSH and FT4 levels of women during pregnancy. Mean TSH level was significantly higher at diagnosis of hypothyroidism as compared to the other three test times (performed 2, 4, or 6 months after diagnosis). No differences were found in TSH levels at 2, 4, and 6 months. No significant differences were also found when mean FT4 levels during pregnancy were compared.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0060" class="elsevierStylePara elsevierViewall">Six women (5% of the sample) had TSH levels higher than 4.5<span class="elsevierStyleHsp" style=""></span>mIU/mL in one test, and three of them had thyroid antibodies. This occurred in three women at the month 2 test, in two women at the month 4 test, and in one woman at the month 6 test. In all these women, titration of thyroxine dose to 100<span class="elsevierStyleHsp" style=""></span>μg/day allowed for maintaining TSH levels within the desired range until delivery.</p><p id="par0065" class="elsevierStylePara elsevierViewall">A woman (0.9% of the sample) had a TSH level less than 0.3<span class="elsevierStyleHsp" style=""></span>mIU/mL in the test performed at 4 months. Thyroxine dose reduction to 50<span class="elsevierStyleHsp" style=""></span>μg/day allowed for maintaining her TSH levels within the desired range until delivery.</p><p id="par0070" class="elsevierStylePara elsevierViewall">At diagnosis of hypothyroidism, weights of pregnant women in the first and fourth quartiles of weight were 53.3<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.9<span class="elsevierStyleHsp" style=""></span>kg and 79<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>11<span class="elsevierStyleHsp" style=""></span>kg, respectively (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.001). Plasma TSH levels of pregnant women in the first quartile of weight were not significantly different from those of women in the fourth quartile neither at diagnosis nor at the tests performed at 2 or 6 months. In the month 4 tests, plasma TSH levels were significantly lower in pregnant women in the first quartile of weight as compared to the fourth quartile (1.82 vs 2.22<span class="elsevierStyleHsp" style=""></span>mIU/mL; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.04). One of the six women who required a higher thyroxine dose was in the first quartile of weight, while the remaining five women were in the second and third quartiles (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>).</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0075" class="elsevierStylePara elsevierViewall">At diagnosis of hypothyroidism, plasma TSH levels of pregnant women in the first and fourth quartiles of TSH levels were 4.77<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.17 and 7.74<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.14<span class="elsevierStyleHsp" style=""></span>mIU/mL, respectively (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.001). No significant differences were seen in plasma TSH levels between women in the first and fourth quartiles of TSH in the tests performed at 2 months (1.95 vs 2.66<span class="elsevierStyleHsp" style=""></span>mIU/mL; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.08), 4 months (2.56 vs 2.48<span class="elsevierStyleHsp" style=""></span>mIU/mL; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.78), or 6 months (2.31 vs 2.21<span class="elsevierStyleHsp" style=""></span>mIU/mL; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.19) since diagnosis of hypothyroidism. Of the six patients in whom thyroxine dose was increased, one was in the first quartile of TSH levels at diagnosis, while three were in the third quartile and two in the fourth quartile.</p><p id="par0080" class="elsevierStylePara elsevierViewall">In the tests conducted at 2 months, 29 women (27% of the sample) has TSH levels higher than recommended by the ATA-AACE but lower than 4.5<span class="elsevierStyleHsp" style=""></span>mIU/mL, which were maintained until delivery. Fifty-four pregnant women (48% of the sample) had at least one TSH value prior to pregnancy. The mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>standard deviation of TSH levels was 3.3<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.9<span class="elsevierStyleHsp" style=""></span>mIU/mL.</p><p id="par0085" class="elsevierStylePara elsevierViewall">Forty-three patients (37% of the sample) had thyroid antibodies (thyroglobulin and/or peroxidase antibodies). Four of the six patients who required increased thyroxine doses during pregnancy belonged to this group.</p><p id="par0090" class="elsevierStylePara elsevierViewall">Of the four women in whom pregnancy did not reach its term, three had thyroid antibodies. The last TSH level before termination of their pregnancies was not significantly different from the mean value in the sample at that time.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Discussion</span><p id="par0095" class="elsevierStylePara elsevierViewall">The range of TSH levels we have considered adequate in pregnant women in this study is not the same as recommended by the ATA-AACE. This is not an uncommon occurrence: a recent report showed that the upper limit for TSH levels in pregnant women used in different Spanish regions ranged from 2.63 and 4.75<span class="elsevierStyleHsp" style=""></span>mIU/mL.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> Fear of overtreatment is a factor that limits use of stricter ranges in actual clinical practice. Uncertainty about the clinical impact of subclinical hypothyroidism on pregnancy has also prompted use of wider TSH ranges by clinicians. Adoption of stricter TSH ranges would also increase prevalence of hypothyroidism to an extent difficult to assume by already overburdened clinical departments.</p><p id="par0100" class="elsevierStylePara elsevierViewall">We do not know whether or not intake of iron or multivitamin preparations by the group of women who required an increased thyroxine dose was similar to that of all other women. Three of the four women in whom pregnancy did not reach its term had thyroid antibodies (i.e. 75%, higher than the prevalence of these antibodies in the whole sample). Both circumstances may have led to bias limiting the conclusions of this study.</p><p id="par0105" class="elsevierStylePara elsevierViewall">Our data suggest that in pregnant women with subclinical hypothyroidism in whom the goal is to achieve TSH levels ranging from 0.3 to 4.5<span class="elsevierStyleHsp" style=""></span>mIU/mL, there is no need to calculate the initial thyroxine dose based on patient weight or TSH level. A daily dose of 75<span class="elsevierStyleHsp" style=""></span>μg of thyroxine is adequate in most these patients.</p><p id="par0110" class="elsevierStylePara elsevierViewall">In fact, the thyroxine dose calculated based on weight or TSH level appears to be low: administration of 1<span class="elsevierStyleHsp" style=""></span>μg/kg/day to this cohort would result in a mean daily dose of 65<span class="elsevierStyleHsp" style=""></span>μg; if TSH levels were used, only pregnant women with values higher than 12<span class="elsevierStyleHsp" style=""></span>mIU/mL would receive 75<span class="elsevierStyleHsp" style=""></span>μg/day of thyroxine.</p><p id="par0115" class="elsevierStylePara elsevierViewall">Our data suggest that if the goal was a TSH level within the ranges recommended by the ATA-AACE, 75<span class="elsevierStyleHsp" style=""></span>μg/day of thyroxine would often be an inadequate dose. A dose of 100<span class="elsevierStyleHsp" style=""></span>μg/day would probably be more adequate under these conditions.</p><p id="par0120" class="elsevierStylePara elsevierViewall">Despite the increase in weight over the course of pregnancy, the thyroxine dose needed by our cohort did not increase. This may be explained by the limited capacity of thyroxine to cross the placenta, so that its actual volume of distribution changes little over these months.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a></p><p id="par0125" class="elsevierStylePara elsevierViewall">We recommend clinicians use of 75<span class="elsevierStyleHsp" style=""></span>μg/day as initial thyroxine dose in any pregnant woman with subclinical hypothyroidism–regardless of weight and TSH level–if the goal is to achieve a TSH level less than 4.5<span class="elsevierStyleHsp" style=""></span>mIU/mL.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Conflicts of interest</span><p id="par0130" class="elsevierStylePara elsevierViewall">The authors state that they have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:10 [ 0 => array:2 [ "identificador" => "xres355395" "titulo" => array:5 [ 0 => "Abstract" 1 => "Background and objectives" 2 => "Patients and methods" 3 => "Results" 4 => "Conclusions" ] ] 1 => array:2 [ "identificador" => "xpalclavsec336659" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "xres355396" "titulo" => array:5 [ 0 => "Resumen" 1 => "Antecedentes y objetivos" 2 => "Pacientes y métodos" 3 => "Resultados" 4 => "Conclusiones" ] ] 3 => array:2 [ "identificador" => "xpalclavsec336660" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Subjects and methods" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Results" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Discussion" ] 8 => array:2 [ "identificador" => "sec0025" "titulo" => "Conflicts of interest" ] 9 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2013-10-07" "fechaAceptado" => "2014-01-26" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec336659" "palabras" => array:5 [ 0 => "Hypothyroidism" 1 => "Pregnancy" 2 => "Dose" 3 => "Treatment" 4 => "Thyroxine" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec336660" "palabras" => array:5 [ 0 => "Hipotiroidismo" 1 => "Gestación" 2 => "Dosis" 3 => "Tratamiento" 4 => "Tiroxina" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span class="elsevierStyleSectionTitle" id="sect0010">Background and objectives</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Treatment of hypothyroid pregnant women is usually calculated based on weight (1<span class="elsevierStyleHsp" style=""></span>μg/kg/day) and TSH levels. This study assessed the usefulness of treating these women with a fixed dose of 75<span class="elsevierStyleHsp" style=""></span>μg/day.</p> <span class="elsevierStyleSectionTitle" id="sect0015">Patients and methods</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">All women with pregnancy diagnosed from January to August 2012 in the Vigo Health Area (Spain) without previous diagnosis of thyroid disease or thyroxine treatment and with TSH levels over 4.5<span class="elsevierStyleHsp" style=""></span>mUI/mL were enrolled by consecutive sampling. All 116 women in the sample were treated with a fixed daily dose of thyroxine 75<span class="elsevierStyleHsp" style=""></span>μg-thyroxine levels were measured at two, four, and six months, and thyroxine dose was modified if TSH level was lower than 0.3 or higher than 4.5<span class="elsevierStyleHsp" style=""></span>mUI/mL.</p> <span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">A woman had a TSH level less than 0.3<span class="elsevierStyleHsp" style=""></span>mUI/mL in a test; reduction of thyroxine dose to 50<span class="elsevierStyleHsp" style=""></span>μg/day allowed for maintaining TSH level within the desired range until delivery. Six women had TSH levels over 4.5<span class="elsevierStyleHsp" style=""></span>mUI/mL in one test; in all of them, increase in thyroxine dose to 100<span class="elsevierStyleHsp" style=""></span>μg/day allowed for maintaining the level within the desired range until delivery.</p> <span class="elsevierStyleSectionTitle" id="sect0025">Conclusions</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Fixed daily doses of thyroxine 75<span class="elsevierStyleHsp" style=""></span>μg allowed for achieving goal TSH levels in most of our pregnant women with subclinical hypothyroidism, irrespective of their weight and baseline TSH level.</p>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span class="elsevierStyleSectionTitle" id="sect0035">Antecedentes y objetivos</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Los métodos habituales de cálculo de la dosis inicial de tiroxina en el tratamiento de gestantes hipotiroideas usan el peso de las pacientes (1<span class="elsevierStyleHsp" style=""></span>μg/kg/día) o la concentración plasmática de TSH. Este estudio analiza la idoneidad de tratar a estas mujeres con una dosis fija de 75<span class="elsevierStyleHsp" style=""></span>μg/día de la hormona.</p> <span class="elsevierStyleSectionTitle" id="sect0040">Pacientes y métodos</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Se seleccionaron mediante un muestreo consecutivo a todas aquellas mujeres diagnosticadas de gestación en el área sanitaria de Vigo entre enero y agosto de 2012, sin antecedentes de tiroidopatía y con una concentración de TSH superior a 4,5<span class="elsevierStyleHsp" style=""></span>mUI/ml y T4L normal. Las 116 gestantes de la muestra resultante recibieron tratamiento con 75<span class="elsevierStyleHsp" style=""></span>μg/día de tiroxina, y se les hizo un análisis a los 2, 4 y 6 meses tras la instauración del tratamiento, modificándose la dosis de la hormona si la concentración de TSH era inferior a 0,3 o superior a 4,5<span class="elsevierStyleHsp" style=""></span>mUI/ml.</p> <span class="elsevierStyleSectionTitle" id="sect0045">Resultados</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Una de las pacientes tuvo, en un análisis, una concentración de TSH inferior a 0,3<span class="elsevierStyleHsp" style=""></span>mUI/ml; el descenso de la dosis de tiroxina a 50<span class="elsevierStyleHsp" style=""></span>μg/día permitió mantener dicha concentración en el rango deseado hasta el parto. Seis tuvieron en un análisis una concentración de TSH superior a 4,5<span class="elsevierStyleHsp" style=""></span>mUI/ml; en todas ellas el aumento de la dosis de tiroxina a 100<span class="elsevierStyleHsp" style=""></span>μg/día permitió mantener dicha concentración en el rango deseado hasta el parto.</p> <span class="elsevierStyleSectionTitle" id="sect0050">Conclusiones</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Una dosis de tiroxina 75<span class="elsevierStyleHsp" style=""></span>μg/día permitió conseguir los objetivos de concentración de TSH de nuestro estudio en la mayoría de las gestantes con hipotiroidismo subclínico, independientemente de su peso y de su concentración inicial de TSH.</p>" ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Please cite this article as: Penin M, Trigo C, López Y, Barragáns M. Tratamiento del hipotiroidismo subclínico en gestantes con una dosis fija diaria de 75<span class="elsevierStyleHsp" style=""></span>μg de tiroxina. Endocrinol Nutr. 2014;61:347–350.</p>" ] ] "multimedia" => array:2 [ 0 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">The column “Diagnosis” shows the value of variables at diagnosis of hypothyroidism. All other columns give the value in the tests performed 2, 4, and 6 months after that time.</p><p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">TSH, thyroid-stimulating hormone.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Diagnosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">2 months \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">4 months \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">6 months \t\t\t\t\t\t\n \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Age (years) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">28<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Gestational age (weeks) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">10.1<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>3.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Weight (kg) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">65.4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>12.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">69.1<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>13.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">73.4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>12.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">79.3<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>11.4 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">TSH (mIU/mL) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5.9<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.3<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.3<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.2<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.1 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">FT4 (ng/100<span class="elsevierStyleHsp" style=""></span>mL) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.1<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.1<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.0<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.0<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.2 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab530589.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Age, gestational age, and hormone levels (mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>standard deviation) during pregnancy.</p>" ] ] 1 => array:7 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:3 [ "leyenda" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Given as mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>standard deviation. The last column represents the number of patients in whom thyroxine dose during pregnancy.</p><p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">TSH, thyroid-stimulating hormone.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">TSH at diagnosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">TSH at 2 months \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">TSH at 4 months \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">TSH at 6 months \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Dose increases \t\t\t\t\t\t\n \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1st quartile \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5.9<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.8<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.8<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">*</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.7<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2nd quartile \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7.9<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.9<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.6<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3rd quartile \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5.8<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.8<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.6<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.5<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4th quartile \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5.8<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.2<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.2<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.1<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">*</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.8<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab530590.png" ] ] ] "notaPie" => array:1 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "*" "nota" => "<p class="elsevierStyleNotepara" id="npar0005"><span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.04.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">TSH levels (mIU/mL) by quartiles of weight at diagnosis of hypothyroidism and after 2, 4, and 6 months.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:9 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "On the need for universal thyroid screening in pregnant women" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L.L. Vila" 1 => "I. Velasco" 2 => "S. González" 3 => "F. Morales" 4 => "E. Sánchez" 5 => "S. Torrejón" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1530/EJE-13-0561" "Revista" => array:6 [ "tituloSerie" => "Eur J Endocrinol" "fecha" => "2014" "volumen" => "170" "paginaInicial" => "R17" "paginaFinal" => "R30" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24128429" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Establishment of reference range for thyroid hormones in normal pregnant Indian women" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.K. Marwaha" 1 => "S. Chopra" 2 => "S. Gopalakrishnan" 3 => "B. Sharma" 4 => "R.S. Kanwar" 5 => "A. Sastry" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1471-0528.2008.01673.x" "Revista" => array:6 [ "tituloSerie" => "BJOG" "fecha" => "2008" "volumen" => "115" "paginaInicial" => "602" "paginaFinal" => "606" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18333941" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "R. Negro" 1 => "A. Schwartz" 2 => "R. Gismondi" 3 => "A. Tinelli" 4 => "T. Mangieri" 5 => "A. Stagnaro-Green" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2009-2009" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2010" "volumen" => "95" "paginaInicial" => "1699" "paginaFinal" => "1707" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20130074" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Management of thyiroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. De Groot" 1 => "M. Abalovich" 2 => "E.K. Alexander" 3 => "N. Amino" 4 => "L. Barbour" 5 => "R.H. Cobin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2011-2803" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2012" "volumen" => "97" "paginaInicial" => "2543" "paginaFinal" => "2565" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22869843" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hypothyroidism during pregnancy: clinical manifestations, diagnosis and treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "D. Ross" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:1 [ "fecha" => "2012" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical practice guidelines for hypothyroidism in adults" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.R. Garber" 1 => "R.H. Cobin" 2 => "H. Gharib" 3 => "J.V. Hennessey" 4 => "I. Klein" 5 => "J.I. Mechanick" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4158/EP12280.GL" "Revista" => array:6 [ "tituloSerie" => "Endocr Pract" "fecha" => "2012" "volumen" => "18" "paginaInicial" => "988" "paginaFinal" => "1028" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23246686" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment with fixed thyroxine doses in pregnant women with subclinical hypothyroidism" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "I. Seoane" 1 => "M. Penín" 2 => "R. Luna" 3 => "R. García-Mayor" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.endonu.2012.02.003" "Revista" => array:6 [ "tituloSerie" => "Endocrinol Nutr" "fecha" => "2012" "volumen" => "59" "paginaInicial" => "284" "paginaFinal" => "287" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22445078" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Detection of thyroid dysfunction in pregnant women: universal screening is justified" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Vila" 1 => "I. Velasco" 2 => "S. González" 3 => "F. Morales" 4 => "E. Sánchez" 5 => "J.L. Lailla" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.endonu.2012.06.014" "Revista" => array:6 [ "tituloSerie" => "Endocrinol Nutr" "fecha" => "2012" "volumen" => "59" "paginaInicial" => "547" "paginaFinal" => "560" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23099114" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Delivery of maternal thyroid hormones to the fetus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J. Patel" 1 => "K. Landers" 2 => "H. Li" 3 => "R.H. Mortimer" 4 => "K. Richard" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Trends Endocrinol Metabol" "fecha" => "2011" "volumen" => "22" "paginaInicial" => "164" "paginaFinal" => "170" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735093/0000006100000007/v1_201407280036/S2173509314001226/v1_201407280036/en/main.assets" "Apartado" => array:4 [ "identificador" => "5824" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735093/0000006100000007/v1_201407280036/S2173509314001226/v1_201407280036/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173509314001226?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 October | 64 | 2 | 66 |
2024 September | 119 | 3 | 122 |
2024 August | 101 | 4 | 105 |
2024 July | 95 | 7 | 102 |
2024 June | 78 | 5 | 83 |
2024 May | 82 | 4 | 86 |
2024 April | 91 | 6 | 97 |
2024 March | 112 | 2 | 114 |
2024 February | 159 | 11 | 170 |
2024 January | 185 | 12 | 197 |
2023 December | 155 | 22 | 177 |
2023 November | 125 | 15 | 140 |
2023 October | 138 | 14 | 152 |
2023 September | 84 | 9 | 93 |
2023 August | 103 | 7 | 110 |
2023 July | 80 | 11 | 91 |
2023 June | 98 | 14 | 112 |
2023 May | 107 | 9 | 116 |
2023 April | 86 | 11 | 97 |
2023 March | 72 | 13 | 85 |
2023 February | 79 | 9 | 88 |
2023 January | 98 | 9 | 107 |
2022 December | 63 | 5 | 68 |
2022 November | 42 | 13 | 55 |
2022 October | 48 | 19 | 67 |
2022 September | 45 | 19 | 64 |
2022 August | 54 | 14 | 68 |
2022 July | 44 | 13 | 57 |
2022 June | 34 | 7 | 41 |
2022 May | 45 | 23 | 68 |
2022 April | 70 | 16 | 86 |
2022 March | 109 | 16 | 125 |
2022 February | 90 | 8 | 98 |
2022 January | 65 | 10 | 75 |
2021 December | 56 | 11 | 67 |
2021 November | 42 | 11 | 53 |
2021 October | 37 | 18 | 55 |
2021 September | 56 | 38 | 94 |
2021 August | 58 | 28 | 86 |
2021 July | 43 | 20 | 63 |
2021 June | 35 | 16 | 51 |
2021 May | 52 | 11 | 63 |
2021 April | 138 | 18 | 156 |
2021 March | 107 | 14 | 121 |
2021 February | 95 | 11 | 106 |
2021 January | 115 | 9 | 124 |
2020 December | 93 | 10 | 103 |
2020 November | 79 | 18 | 97 |
2020 October | 55 | 7 | 62 |
2020 September | 58 | 11 | 69 |
2020 August | 78 | 7 | 85 |
2020 July | 53 | 13 | 66 |
2020 June | 65 | 3 | 68 |
2020 May | 73 | 9 | 82 |
2020 April | 74 | 5 | 79 |
2020 March | 64 | 4 | 68 |
2020 February | 52 | 4 | 56 |
2020 January | 49 | 9 | 58 |
2019 December | 53 | 4 | 57 |
2019 November | 55 | 13 | 68 |
2019 October | 43 | 6 | 49 |
2019 September | 26 | 9 | 35 |
2019 August | 26 | 2 | 28 |
2019 July | 23 | 17 | 40 |
2019 June | 35 | 10 | 45 |
2019 May | 96 | 20 | 116 |
2019 April | 27 | 9 | 36 |
2019 March | 11 | 3 | 14 |
2019 February | 11 | 8 | 19 |
2019 January | 5 | 10 | 15 |
2018 December | 8 | 4 | 12 |
2018 November | 6 | 1 | 7 |
2018 October | 8 | 2 | 10 |
2018 September | 11 | 2 | 13 |
2018 August | 6 | 3 | 9 |
2018 July | 15 | 4 | 19 |
2018 June | 6 | 1 | 7 |
2018 May | 15 | 3 | 18 |
2018 April | 8 | 1 | 9 |
2018 March | 11 | 0 | 11 |
2018 February | 7 | 0 | 7 |
2018 January | 11 | 0 | 11 |
2017 December | 11 | 1 | 12 |
2017 November | 9 | 1 | 10 |
2017 October | 19 | 1 | 20 |
2017 September | 19 | 2 | 21 |
2017 August | 19 | 5 | 24 |
2017 July | 15 | 3 | 18 |
2017 June | 29 | 7 | 36 |
2017 May | 24 | 3 | 27 |
2017 April | 35 | 3 | 38 |
2017 March | 27 | 4 | 31 |
2017 February | 28 | 3 | 31 |
2017 January | 10 | 1 | 11 |
2016 December | 15 | 4 | 19 |
2016 November | 17 | 5 | 22 |
2016 October | 32 | 2 | 34 |
2016 September | 29 | 5 | 34 |
2016 August | 16 | 1 | 17 |
2016 July | 26 | 5 | 31 |
2016 June | 21 | 7 | 28 |
2016 May | 32 | 9 | 41 |
2016 April | 23 | 8 | 31 |
2016 March | 36 | 5 | 41 |
2016 February | 15 | 10 | 25 |
2016 January | 35 | 9 | 44 |
2015 December | 21 | 9 | 30 |
2015 November | 23 | 5 | 28 |
2014 October | 0 | 1 | 1 |
2014 September | 2 | 1 | 3 |
2014 August | 1 | 2 | 3 |